Expert Presentations - Automated Insulin Delivery

Expert Presentations - Type 2 Diabetes

Clinical Evidence - Automated Insulin Delivery

Yes

Related Resources

ATTD 2025 - Dexcom CGM: All Ages All Stages of Diabetes

Podcast Episode 24: Type 2 Diabetes Management Through Glucose Tracking

Premium Content

The Role of CGM and Automated Insulin Delivery (AID) Systems in Pregnancy

OlgaDalisay — Tue, 21 May 2024 17:32:55 +0000

The Role of CGM and Automated Insulin Delivery (AID) Systems in Pregnancy

05/24/2024

OlgaDalisay Tue, 05/21/2024 - 17:32

A perspective from the United Kingdom

^{The information you see or hear at this event provides details about medical products which are not available in all countries, may have different indications, and/or have not received approval or market clearance by all governmental regulatory bodies throughout the world. Nothing shown or stated herein should be construed as a solicitation, advertisement, or promotion of any product, or of an indication of any specific use for any product, which is not authorized by the laws and regulations of the country where you reside.}

^{The content may include the presenter’s own experience sharing and data – please do not record or distribute the presentation slides.}

This short presentation was delivered during the recent ATTD Diabetes Congress in Italy.

Managing diabetes during pregnancy is critical for maternal and fetal health. Pregnancy induces physiological changes that affect insulin sensitivity, complicating glycemic control.¹ Poorly managed diabetes can lead to adverse outcomes such as preeclampsia, preterm birth, and congenital malformations.² Utilizing continuous glucose monitoring (CGM) technology allows for real-time glucose tracking, facilitating tighter glycemic control.³ This proactive management is essential in minimizing hyperglycemia and hypoglycemia, thus improving both maternal and neonatal outcomes.⁴ Close monitoring and interdisciplinary care are vital for optimizing pregnancy outcomes in women with diabetes.⁵

Dr Helen Murphy is a Professor of Medicine (Diabetes and Antenatal Care) at the University of East Anglia, and a practicing clinician (Norfolk & Norwich University Hospital NHS Trust), Norwich, UK.

She runs a diabetes pregnancy research program which aims to support women with diabetes to achieve the pregnancy glucose targets required for optimal mother and baby health outcomes. She co-led the CONCEPTT Continuous Glucose Monitoring (CGM) trial. CONCEPTT demonstrated health benefits for mothers with type 1 diabetes (T1D), their newborn infants and the potential for substantial healthcare cost savings. In addition to scientific contributions, building research infrastructure and supporting the next generation of clinical academics, data from CONCEPTT led to international changes in clinical practice, CGM is now the recognized standard of care for pregnant women with T1D.

In this short ~20 min presentation, Dr Murphy will talk about the specifics of diabetes management in pregnant individuals across the United Kingdom, including:

National Diabetes in Pregnancy Audit
CGM use before and during Type 1 diabetes pregnancy
AiDAPT randomized trial results

^{Catalano, P. M., & Tyzbir, E. D. (1991). Effects of pregnancy on insulin sensitivity and beta-cell function in women with and without gestational diabetes.}^{American Journal of Obstetrics and Gynecology}^{, 165(3), 579-585.}
^{Reece, E. A., Leguizamon, G., & Wiznitzer, A. (2009). Gestational diabetes: the need for a common ground.}^{The Lancet}^{, 373(9677), 1789-1797.}
^{Voormolen, D. N., de Wit, L., van Rijn, B. B., Koster, M. P., de Valk, H. W., & Franx, A. (2018). Continuous glucose monitoring during pregnancy: An overview of recent studies.}^{Journal of Diabetes Science and Technology}^{, 12(5), 955-960.}
^{Murphy, H. R., et al. (2008). Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial.}^BMJ^{, 337, a1680.}
^{Yogev, Y., & Langer, O. (2008). Pregnancy outcome in diabetic patients.}^{Best Practice & Research Clinical Obstetrics & Gynaecology}^{, 22(6), 1041-1057}

Expert Presentations - Data Interpretation

Clinical Evidence

Clinical Evidence - Automated Insulin Delivery

Pregnancy

Premium Content

Advancing Use and Access of AID Systems in the United Kingdom

OlgaDalisay — Tue, 23 Apr 2024 02:20:14 +0000

Advancing Use and Access of AID Systems in the United Kingdom

04/22/2024

OlgaDalisay Tue, 04/23/2024 - 02:20

Presented at ATTD 2024

In this brief ~9 min presentation by Prof Partha Kar, FRCP (Portsmouth, England) you will learn about the latest advancements in the use of Automated Insulin Delivery (AID) systems in the UK region. Prof. Kar will cover:

Past and current state of AID access
Latest advancements in clinical research around AID
Common challenges providers face around access to AID systems, and more...

^{The content may include the presenter’s own experience sharing and data – please do not record or distribute the presentation slides.}

Events

Systematic Review of Commercial Hybrid Closed-Loop AID Systems

ATTD

Country

United Kingdom

Australia

Professor Partha Kar is a Consultant in Diabetes & Endocrinology, Portsmouth, England and National Specialty Advisor for Diabetes for NHS England. He has led and delivered so far on (April 2016- till date):

Freestyle Libre being available on NHS -across country
NHS Right Care Diabetes pathway
Diabetes “Language Matters” document
Type 1 diabetes NHS England web-resource – on NHS choices
Introduction of Frailty into QoF treatment targets for diabetes care in NHS
Availability of CGM to all T1D pregnant patients
Diabetes Technology pathway development with multiple stakeholders
Setting up pilot projects for diabulimia treatment in London & Wessex Introduction of Low Carbohydrate App into NHS Apps Library

Related Resources

The Role of CGM and Automated Insulin Delivery (AID) Systems in Pregnancy

Premium Content

Innovations Designed to Empower Clinicians, Educators and Caregivers

OlgaDalisay — Mon, 18 Dec 2023 16:38:27 +0000

Innovations Designed to Empower Clinicians, Educators and Caregivers

12/18/2023

OlgaDalisay Mon, 12/18/2023 - 16:38

Tune in to this ~17 min presentation from Diabetes Technology Meeting that took place virtually in November 2023. Peter Simpson, Sr Vice President of Advanced Research & Technology at Dexcom provides an overview of Dexcom's growing ecosystem of highly innovative solutions for diabetes management.

You will learn about current products and take a sneak peek at what's to come in the future for this rapidly evolving medical device technology. In addition, this presentation will cover:

Automated Insulin Delivery (AID) integrations and solutions that can provide your patients with more choice and personalization of their diabetes management
New Dexcom G7 enhancements
New integration with Tandem t:slim X2 pump
New Beta Bionics and Dexcom G7 Fully Closed Loop system

Expert Presentations - Data Interpretation

Expert Presentations - Type 2 Diabetes

Diabetes Technology

COMISAIR 1 year follow up

Country

United States

Premium Content

EASD 2023: Real-Time CGM Clinical Outcomes – The 7-Year COMISAIR Data

OlgaDalisay — Tue, 17 Oct 2023 02:01:23 +0000

EASD 2023: Real-Time CGM Clinical Outcomes – The 7-Year COMISAIR Data

10/16/2023

OlgaDalisay Tue, 10/17/2023 - 02:01

Unpublished. Presented at EASD 2023 in Hamburg, Germany. October 2, 2023

In this 20 min presentation you will learn about Comparison of different treatment modalities for Type 1 diabetes Including Sensor-Augmented Insulin Regimens in 7 years of follow-up: the COMISAIR study.

COMISAIR study is currently the longest CGM clinical trial. Outcomes suggest solid evidence about benefits of continuous glucose monitoring. Below are the key takeaways from the study:

CGM provided significant and stable improvement of glycemic outcomes.
Treatment with CGM and MDI was more effective than PUMP therapy alone.
CGM and MDI can be an alternative to PUMPS and CGM but are inferior to AID.
The trial suggests a lower risk of diabetic retinopathy with CGM compared to SMBG.

COMISAIR 3 year follow up

Clinical Evidence - Type 1 Diabetes

Clinical Evidence

Clinical Evidence - Automated Insulin Delivery

EASD 2023

Premium Content

Exclusive! Diabetes Technology Advancements at ATDC 2022

OlgaDalisay — Fri, 26 Aug 2022 17:07:18 +0000

Exclusive! Diabetes Technology Advancements at ATDC 2022

08/25/2022

OlgaDalisay Fri, 08/26/2022 - 17:07

This presentation was originally presented at Keystone in July 2022 at annual ATDC conference.

Dr. Swamy will share her journey as she discusses her current use of diabetes technology in clinical practice from providing her type 1 patients access to CGM early in diagnosis, all the way through onboarding to automated insulin delivery (AID) systems.

Cari Berget will follow with data on how to get the best from these devices using the CARES paradigm and will review pragmatic approaches to using AID systems in clinical practice.

Available only on SIGMA!

anitaswamy@hotmail.com

cari.berget

Events

Diabetes Technology